These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 17950274)
1. IL-6-174 C/G polymorphism in the gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Berković MC; Jokić M; Marout J; Radosević S; Zjacić-Rotkvić V; Kapitanović S Exp Mol Pathol; 2007 Dec; 83(3):474-9. PubMed ID: 17950274 [TBL] [Abstract][Full Text] [Related]
2. TNF-alpha promoter single nucleotide polymorphisms in gastroenteropancreatic neuroendocrine tumors. Berković M; Cacev T; Zjacić-Rotkvić V; Kapitanović S Neuroendocrinology; 2006; 84(5):346-52. PubMed ID: 17164537 [TBL] [Abstract][Full Text] [Related]
3. IL-2 -330 T/G SNP and serum values-potential new tumor markers in neuroendocrine tumors of the gastrointestinal tract and pancreas (GEP-NETs). Berković MC; Jokić M; Marout J; Radosević S; Zjacić-Rotkvić V; Kapitanović S J Mol Med (Berl); 2010 Apr; 88(4):423-9. PubMed ID: 20049409 [TBL] [Abstract][Full Text] [Related]
7. Relationship between interleukin 6 promoter polymorphism at position -174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica. Boiardi L; Casali B; Farnetti E; Pipitone N; Nicoli D; Cantini F; Macchioni P; Bajocchi G; Catanoso MG; Pulsatelli L; Consonni D; Salvarani C J Rheumatol; 2006 Apr; 33(4):703-8. PubMed ID: 16583473 [TBL] [Abstract][Full Text] [Related]
8. Chromogranin A as a biochemical marker for the management of neuroendocrine tumors: a multicenter study developed in Argentina. Belli SH; Oneto A; Aranda C; O'Connor JM; Domenichini E; Roca E; Méndez G; Bestani MC; Parma P; Giacomi N; Marmissolle F Acta Gastroenterol Latinoam; 2009 Sep; 39(3):184-9. PubMed ID: 19845257 [TBL] [Abstract][Full Text] [Related]
10. Molecular genetics of gastroenteropancreatic neuroendocrine tumors. Toumpanakis CG; Caplin ME Am J Gastroenterol; 2008 Mar; 103(3):729-32. PubMed ID: 18341492 [TBL] [Abstract][Full Text] [Related]
11. [Correlation of serum IL-18 level and IL-18 gene promoter polymorphisms to the risk of cervical cancer]. Qi T; Wang Q; Zheng L; Yang HL; Bao J Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):754-7. PubMed ID: 18504197 [TBL] [Abstract][Full Text] [Related]
12. -174 G>C polymorphism of interleukin 6 gene promoter affects interleukin 6 serum level in patients with colorectal cancer. Belluco C; Olivieri F; Bonafè M; Giovagnetti S; Mammano E; Scalerta R; Ambrosi A; Franceschi C; Nitti D; Lise M Clin Cancer Res; 2003 Jun; 9(6):2173-6. PubMed ID: 12796383 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-6-174 G/C polymorphism is not associated with IL-6 expression and susceptibility to sporadic colon cancer. Cacev T; Jokić M; Loncar B; Krizanac S; Kapitanović S DNA Cell Biol; 2010 Apr; 29(4):177-82. PubMed ID: 20132036 [TBL] [Abstract][Full Text] [Related]
14. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors. Pape UF; Jann H; Müller-Nordhorn J; Bockelbrink A; Berndt U; Willich SN; Koch M; Röcken C; Rindi G; Wiedenmann B Cancer; 2008 Jul; 113(2):256-65. PubMed ID: 18506737 [TBL] [Abstract][Full Text] [Related]
15. Chromogranin A as a marker of neuroendocrine neoplasia: an Italian Multicenter Study. Zatelli MC; Torta M; Leon A; Ambrosio MR; Gion M; Tomassetti P; De Braud F; Delle Fave G; Dogliotti L; degli Uberti EC; Endocr Relat Cancer; 2007 Jun; 14(2):473-82. PubMed ID: 17639060 [TBL] [Abstract][Full Text] [Related]
16. Cytokine genotypes in acute pancreatitis: association with etiology, severity, and cytokine levels in blood. de-Madaria E; Martínez J; Sempere L; Lozano B; Sánchez-Payá J; Uceda F; Pérez-Mateo M Pancreas; 2008 Oct; 37(3):295-301. PubMed ID: 18815552 [TBL] [Abstract][Full Text] [Related]
17. The interleukin-6 (IL6)-174 G/C promoter genotype is associated with the presence of septic shock and the ex vivo secretion of IL6. Tischendorf JJ; Yagmur E; Scholten D; Vidacek D; Koch A; Winograd R; Gressner AM; Trautwein C; Wasmuth HE; Lammert F Int J Immunogenet; 2007 Dec; 34(6):413-8. PubMed ID: 18001296 [TBL] [Abstract][Full Text] [Related]
18. Genetic variants of IL6 gene promoter influence on C-reactive protein levels but are not associated with susceptibility to invasive pulmonary aspergillosis in haematological patients. Sainz J; Pérez E; Gómez-Lopera S; López-Fernández E; Moratalla L; Oyonarte S; Jurado M Cytokine; 2008 Mar; 41(3):268-78. PubMed ID: 18191407 [TBL] [Abstract][Full Text] [Related]
20. Association of variants in the interleukin-27 and interleukin-12 gene with nasopharyngeal carcinoma. Wei YS; Lan Y; Luo B; Lu D; Nong HB Mol Carcinog; 2009 Aug; 48(8):751-7. PubMed ID: 19148899 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]